Form 4 AGIOS PHARMACEUTICALS For: May 01 Filed by: Schenkein David P
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Agios Pharma (AGIO) PT Raised to $90 at RBC Capital
May 7, 2018 7:39 AM EDTRBC Capital raised its price target on Agios Pharma (NASDAQ: AGIO) to $90.00 (from $88.00) while maintaining an Outperform rating.
Analsyt Kennen MacKay said came away from the R&D day more positive towards the company's internal pipeline and R&D engine. AGIO detailed the broad IDH... More
